Your browser doesn't support javascript.
loading
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Ishigami, Junichi; Taliercio, Jonathan T; Feldman, Harold I; Srivastava, Anand; Townsend, Raymond R; Cohen, Debbie L; Horwitz, Edward J; Rao, Panduranga; Charleston, Jeanne; Fink, Jeffrey C; Ricardo, Ana C; Sondheimer, James; Chen, Teresa K; Wolf, Myles; Isakova, Tamara; Appel, Lawrence J; Matsushita, Kunihiro.
Afiliação
  • Ishigami J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland jishiga1@jhu.edu.
  • Taliercio JT; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Feldman HI; Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Srivastava A; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Townsend RR; Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Cohen DL; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Horwitz EJ; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Rao P; Division of Nephrology, MetroHealth Medical Center, Cleveland, Ohio.
  • Charleston J; Division of Nephrology, University of Michigan, Ann Arbor, Michigan.
  • Fink JC; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Ricardo AC; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
  • Sondheimer J; Division of Nephrology, University of Illinois, Chicago, Illinois.
  • Chen TK; Division of Nephrology and Hypertension, Wayne State University School of Medicine, Detroit, Michigan.
  • Wolf M; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Isakova T; Division of Nephrology, Department of Medicine, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Appel LJ; Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Matsushita K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
J Am Soc Nephrol ; 31(8): 1836-1846, 2020 08.
Article em En | MEDLINE | ID: mdl-32576601
ABSTRACT

BACKGROUND:

Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D-suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population.

METHODS:

In 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding.

RESULTS:

During a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF-α, high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases).

CONCLUSIONS:

Among individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Fatores de Crescimento de Fibroblastos / Hospitalização / Infecções Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Fatores de Crescimento de Fibroblastos / Hospitalização / Infecções Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article